Safe and effective use of chromatographically purified intravenous immunoglobulin despite profound anti-IgA sensitization

Internal Medicine Journal

Volumn 31, Issue 4, 2001, Pages 256-257

  Limaye, S ^a   Walls, R S ^a   Riminton, S ^a  

^a ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; BLOOD TRANSFUSION REACTION; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION; LUNG FUNCTION; PRIORITY JOURNAL; SENSITIZATION;

ANTIBODIES, ANTI-IDIOTYPIC; CHROMATOGRAPHY; COMMON VARIABLE IMMUNODEFICIENCY; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGED;

EID: 0034954096     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2001.00053.x     Document Type: Article

References (5)

1. Anaphylactic reactions after gammaglobulin administration in patients with hypogammaglobulinemia
2. Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy
3. Chromatographic purification of immunoglobulins
4. Haemagglutination assays for the diagnosis and prevention of IgA anaphylactic transfusion reactions
5. Long-term follow-up of anti-IgA antibodies in healthy IgA-deficient adults